Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies
L Mosconi - Clinical and translational imaging, 2013 - Springer
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder associated with
progressive loss of cognitive function. 2-[18 F] fluoro-2-deoxy-d-glucose (FDG) positron …
progressive loss of cognitive function. 2-[18 F] fluoro-2-deoxy-d-glucose (FDG) positron …
Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations
AA Maudsley, OC Andronesi, PB Barker… - NMR in …, 2021 - Wiley Online Library
Magnetic resonance spectroscopic imaging (MRSI) offers considerable promise for
monitoring metabolic alterations associated with disease or injury; however, to date, these …
monitoring metabolic alterations associated with disease or injury; however, to date, these …
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial
JA Luchsinger, T Perez, H Chang… - Journal of …, 2016 - content.iospress.com
Diabetes and hyperinsulinemia may be risk factors for Alzheimer's disease (AD). We
conducted a pilot study of metformin, a medication efficacious in treating and preventing …
conducted a pilot study of metformin, a medication efficacious in treating and preventing …
The logopenic/phonological variant of primary progressive aphasia
Objective: Primary progressive aphasia (PPA) is characterized by isolated decline in
language functions. Semantic dementia and progressive nonfluent aphasia are accepted …
language functions. Semantic dementia and progressive nonfluent aphasia are accepted …
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
PA Della Rosa, C Cerami, F Gallivanone, A Prestia… - Neuroinformatics, 2014 - Springer
Abstract [18 F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely
used diagnostic tool that can detect and quantify pathophysiology, as assessed through …
used diagnostic tool that can detect and quantify pathophysiology, as assessed through …
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics
and an automated voxel-based procedure, is presented and validated in a large data set …
and an automated voxel-based procedure, is presented and validated in a large data set …
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga, N Lautenschlager, H Siebner… - European journal of …, 2003 - Springer
A high percentage of patients with mild cognitive impairment (MCI) develop clinical
dementia of the Alzheimer type (AD) within 1 year. The aim of this longitudinal study was to …
dementia of the Alzheimer type (AD) within 1 year. The aim of this longitudinal study was to …
FDG PET in the differential diagnosis of parkinsonian disorders
The differential diagnosis of parkinsonian disorders can be challenging, especially early in
the disease course. PET imaging with [18F]-fluorodeoxyglucose (FDG) has been used to …
the disease course. PET imaging with [18F]-fluorodeoxyglucose (FDG) has been used to …
[HTML][HTML] Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Diagnostic accuracy in FDG-PET imaging highly depends on the operating procedures. In
this clinical study on dementia, we compared the diagnostic accuracy at a single-subject …
this clinical study on dementia, we compared the diagnostic accuracy at a single-subject …